MENU
CYTH
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Cyclo Therapeutics (CYTH) Ownership - Who owns Cyclo Therapeutics?
Profile
Industry
N/A
Address
6714 North West 16th Street
Phone
+1 386 418-8060
Employees
8
Web
https://www.cyclotherapeutics.com
Details
Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
39.05M
P/E Ratio
N/A
Total Cash
9.25M
Projected Growth
N/A
Total Debt
1.03M
Revenue
1.08M
Risk (Beta)
1.11
Dividend Yield
N/A
Total Cash/Share
0.32
Total Debt/Equity
N/A
Revenue/Share
0.07 USD as % of share price
Fundamentals
CYTH
Capitalization
39.1M
P/E Ratio
N/A
Risk (Beta)
1.11
Dividend Yield
N/A
Total Cash
9.25M
Total Cash/Share
0.32
Total Debt
1.03M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.07%
Revenue
1.08M
ROE
N/A
Book Value
4.76M
P/B Ratio
8.21
Cash Flow
N/A
Earnings
-1.23
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
2.86K
Current Ratio
1.45
Current Revenue Per Employee
38924.88
Dividends Per Share - Security
N/A
EBITDA
-20.03M
Float
N/A
Float - Current
N/A
Gross Income Margin
95.02
Revenue To Assets
-229.72
Shares Held By Institutions
2.8M
Shares Outstanding - Current
28.7M
Total Liabilities
8.49M
Total Volume MTD
N/A
Value
-1
Gain YTD
-58.491
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry PharmaceuticalsOther
Profile
Fundamentals
Details
Industry
N/A
Address
6714 North West 16th Street
Phone
+1 386 418-8060
Employees
8
Web
https://www.cyclotherapeutics.com